Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: A prospective finnish study

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 6, 2009, Pages 2099-2105

  Hu, Gang ^a,b,c   Jousilahti, Pekka ^a   Tuomilehto, Jaakko ^a,b,d   Antikainen, Riitta ^e,f   Sundvall, Jouko ^a   Salomaa, Veikko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^e Oulu City Hospital   (Finland)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COFFEE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DRUG UTILIZATION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; FINLAND; GROUPS BY AGE; HAZARD RATIO; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 66749135254     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2260     Document Type: Article

References (30)

1. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon 3rd RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith Jr SC, Taubert K, Tracy RP, Vinicor F 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511 (Pubitemid 36158056)
2. Festa A, D'Agostino Jr R, Howard G, Mykkänen L, Tracy RP, Haffner SM 2000 Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47 (Pubitemid 30430551)
3. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978
4. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM 2002 Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25:2016-2021 (Pubitemid 41071061)
5. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N 2003 Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26:2754-2757 (Pubitemid 37205542)
6. Snijder MB, Dekker JM, Visser M, Stehouwer CD, Yudkin JS, Bouter LM, Heine RJ, Nijpels G, Seidell JC 2003 Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. Diabetes Care 26:1656-1657
7. Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, Iwase M, Iida M 2005 Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care 28:2497-2500 (Pubitemid 41384300)
8. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N 2002 C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596-1600 (Pubitemid 34826630)
9. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, Koenig W2003 C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 163:93-99 (Pubitemid 36091606)
10. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT 2004 C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47:1403-1410 (Pubitemid 39232426)
11. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334 (Pubitemid 32656163)
12. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G 2003 Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52:1799-1805 (Pubitemid 36792473)
13. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE 2004 Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693-700 (Pubitemid 38270639)
14. Liu S, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, Heiss G, Howard BV, Hotamisligil GS, Hu FB, Kuller LH, Manson JE 2007 A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 167:1676-1685 (Pubitemid 47280350)
15. 1988 Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA project. World Health Stat Q 41:115-140 (Pubitemid 19034355)
16. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P 2000 Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 29:49-56 (Pubitemid 30119707)
17. Hu G, Qiao Q, Silventoinen K, Eriksson JG, Jousilahti P, Lindstrom J, Valle TT, Nissinen A, Tuomilehto J 2003 Occupational, commuting, and leisuretime physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. Diabetologia 46:322-329 (Pubitemid 36547586)
18. Hu G, Lindstrom J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J 2004 Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 164:892-896 (Pubitemid 38520631)
19. Hu G, Eriksson J, Barengo NC, Lakka TA, Valle TT, Nissinen A, Jousilahti P, Tuomilehto J 2004 Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 110:666-673 (Pubitemid 39056264)
20. Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J 2005 Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 36:1994-1999 (Pubitemid 41266540)
21. Hu G, Jousilahti P, Borodulin K, Barengo NC, Lakka TA, Nissinen A, Tuomilehto J 2007 Occupational, commuting and leisure-time physical activity in relation to coronary heart disease among middle-aged Finnish men and women. Atherosclerosis 194:490-497 (Pubitemid 47513083)
22. Hu G, Tuomilehto J, Borodulin K, Jousilahti P 2007 The joint associations of occupational, commuting, and leisure-time physical activity, and the Framingham risk score on the 10-year risk of coronary heart disease. Eur Heart J 28:492-498 (Pubitemid 47343562)
23. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P 2004 Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291:1213-1219 (Pubitemid 38541664)
24. Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J 2006 Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes (Lond) 30:1742-1749 (Pubitemid 44863406)
25. Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J 2008 Coffee consumption, serum γ-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr 62:178-185
26. WHO Consultation 1999 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization
27. Cox DR 1972 Regression models and life tables (with discussion). J R Stat Soc B 34:187-220
28. Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C 2007 Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30:854-860
29. Ding EL, Song Y, Malik VS, Liu S 2006 Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288-1299
30. Folsom AR, Golden SH, Boland LL, Szklo M 2005 Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in postmenopausal women. Eur J Epidemiol 20:1015-1022 (Pubitemid 41752620)